AquiSense to Use NS Nanotech ShortWaveLight™ Emitters in New Research Products


The new AquiSense products will help accelerate the role of UVC and far-UVC light as potent weapons against coronavirus and future pathogens

AquiSense Technologies will integrate NS Nanotech’s solid-state emitters of UVC and far-UVC light into new products for researchers studying the disinfectant properties of light, the companies announced today. AquiSense, the global leader in UVC LED disinfection technology, said its products will be the first to offer academic, government, and private industry researchers access to a semiconductor far-UVC light source.

“The Covid-19 pandemic has created a growing need for better data on the safety and efficacy of UV-C technology,” said AquiSense CEO Oliver Lawal. “We are excited about the research possibilities of lower wavelength solid-state semiconductors integrated into our PearlLab™ product line which are expected to be ready for purchase in 2021.”

NS Nanotech’s ShortWaveLight™ Emitter, announced in November 2020, will be the world’s first solid-state solution to generate far-UVC light at wavelengths of 222 nanometers or less. Recent academic studies have indicated that far-UVC light effectively inactivates human coronaviruses (alpha HCoV-229E¹ and SARS-CoV-2²) and that its shorter wavelength is less harmful to human skin than longer-wavelength UVC light³. While this research is promising, more studies will help solidify these claims, aiding in the expansion and adoption of far UVC technology in the coming months and years.

Two New Research Tools

“We are delighted we can help AquiSense provide the best tools for researchers studying disinfection properties of UVC light, making far-UVC sources broadly available to the research community,” said NS Nanotech CEO Seth Coe-Sullivan. “The new AquiSense products will help accelerate the role of UVC and far-UVC light as potent weapons against coronavirus and future pathogens.”

NS Nanotech’s ShortWaveLight™ Emitters will be used in two new AquiSense research tools.

  • The PearlLab Beam 200-400™ will use the UVC ShortWaveLight™ Emitter, which generates light in the entire range of UV spectrum, from 200-to-400nm. This can be used to study the effects of broadband light as a germicide, or in combination with filter sets to select any UV wavelength of particular interest.
  • The PearlLab Beam 200-230™ will use the Far-UVC ShortWaveLight™ Emitter, which generates light in the narrower far-UVC spectrum range, from 200-to-230nm. This is a critical research tool in any study of the safety and efficacy of far-UVC light.

AquiSense research tools utilize solid-state solutions that are smaller and easier to use than devices that rely on an earlier generation of technology based on mercury lamps that are often expensive, cumbersome, difficult to operate, and potentially dangerous.

About NS Nanotech

NS Nanotech’s patented technologies, drawing on a decade of work on nitride semiconductors by researchers at McGill University and the University of Michigan, dramatically improve the fabrication process and resulting efficiency of nano-scale light-emitting materials. NS Nanotech ShortWaveLight™ Emitters are the first devices that utilize solid-state semiconductors to generate far-UVC light. And the portable, personal ShortWaveAir™ Purifier is a consumer product that emits far-UVC light to neutralize virus and bacteria in the user’s personal airspace.

About AquiSense

AquiSense Technologies is the global leader in UV-C LED systems design and manufacture. They work with leading LED manufacturers to evaluate their devices and then design efficient disinfection products. Using a combination of patented technology and in-depth know-how, AquiSense integrates LED devices into products that solve real world problems in water, air, and surface applications (http://www.aquisense.com).

¹Far-UVC efficacy study (SARS-CoV-2):

  • Effectiveness of 222-nm Ultraviolet Light on Disinfecting SARS-CoV-2 Surface Contamination, American Journal of Infection Control (AJIC), 2020.

²Far-UVC efficacy study (alpha HCoV-229E):

  • Far-UVC Light (222-nm) Efficiently and Safely Inactivates Airborne Human Coronaviruses, Nature, 2020.

³ Far-UVC human safety studies:

  • Repetitive Irradiation with 222-nm UVC Shown to be Non-Carcinogenic & Safe for Sterilizing Human Skin, Kobe University, 2020.
  • Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light, Radiation Research, 2017.

Share article on social media or email:

Leave a Reply